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Abstract
Background: Treponema denticola is strongly associated with the development of periodontal disease. Both synergistic
and antagonistic effects are observed among bacterial species in the process of biofilm formation. Bacteriocin-related
genes have not yet been fully characterized in periodontopathic bacteria. The aim of this study was to detect and
characterize bacteriocin-associated proteins in T. denticola.
Methods: The whole genome sequence of T. denticola ATCC 35405 was screened with a Streptococcus mutans
bacteriocin immunity protein (ImmA/Bip) sequence. The prevalence of homologous genes in T. denticola
strains was then investigated by Southern blotting. Expression of the genes was evaluated by qRT-PCR.
Results: In the genome sequence of T. denticola, an amino acid sequence coded by the open reading frame
TDE_0719 showed 26 % identity with the S. mutans ImmA. Furthermore, two protein sequences encoded by
TDE_0425 and TDE_2431 in T. denticola ATCC 35405 showed ~40 % identity with that coded by TDE_0719.
Therefore, TDE_0425, TDE_0719, and TDE_2431 were designated as tepA1, A2, and A3, respectively. Open reading
frames showing similarity to the HlyD family of secretion proteins were detected downstream of tepA1, A2, and A3.
They were designated as tepB1, B2, and B3, respectively. A gene harboring a bacteriocin-like signal sequence was
detected upstream of tepA1. The prevalence of tepA1 and A2 differed among Treponema species. Susceptibility to
chloramphenicol and ofloxacin was slightly decreased in a tepA2 mutant while that to kanamycin was increased.
Expression of tepA3-B3 was increased in the tepA2 mutant.
Conclusion: These results indicate that T. denticola ATCC 35405 has three potential bacteriocin export proteins and
that the presence of these genes differs among the Treponema strains. TepA3-B3 of the corresponding proteins may
be involved in resistance to chloramphenicol.
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Background
Treponema denticola is a spiral-shaped motile rod that
is frequently isolated from the periodontal pockets of
subjects with chronic periodontitis [1, 2] and that pos-
sesses several potential virulence factors [3]. It is often
co-isolated with Porphyromnas gingivalis and Tannerella
forsythia from the dental plaque biofilms of chronic
periodontitis patients [4] and is involved in the develop-
ment of periodontitis [5, 6].
Interactions among bacterial species that reside in
dental plaque biofilms influence the composition of the
biofilms [7–9]. Microorganisms in biofilms develop their
niche by symbiosis with other microorganisms and sup-
pression of competitors by secreting antagonistic factors
[10, 11]. To suppress the growth of a competitor, various
microorganisms produce antimicrobials such as bacte-
riocins and H2O2 [12]. These antimicrobial factors play
an important role in the survival strategy of the microor-
ganisms in the biofilms. Similarly, in dental plaque
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biofilms, many species of microorganisms have been
reported to produce bacteriocins or bacteriocin-like sub-
stances [13–18]. In the bacteriocin-producing bacteria,
genes encoding a bacteriocin, a bacteriocin ABC trans-
porter, and bacteriocin immunity proteins are involved
in bacteriocin production [19]. Bacteriocin immunity
proteins protect the microbes against the effects of their
own bacteriocins [20]. Bacteriocin ABC transporters
have two functional domains: a peptidase C39 domain,
which is involved in the processing of bacteriocin pre-
cursors at the double glycine, and an ABC transporter
domain, which is involved in the export of the bacterio-
cins [21]. A synergistic effect between T. denticola and
P. gingivalis has been reported [22], while growth of T.
denticola was inhibited by plaque-associated Streptococ-
cus mutans [23]. The antagonistic effects produced by
bacteriocins have been genetically characterized in oral
streptococci [24–26], while those in periodontopathic
bacteria remain to be established. Suppressing the
growth of and avoiding inhibition by competitors
would benefit T. denticola in the colonization of the
subgingival plaque and the development of periodon-
topathic biofilms.
In the present study, we intended to characterize
bacteriocin-associated proteins from T. denticola. By
screening of T. denticola genomic DNA using S. mutans
bacteriocin immunity protein, ABC-type bacteriocin
exporter-like proteins were detected and the function of
the exporter was investigated.
Methods
Bacterial strains and culture conditions
The strains of T. denticola used in this study are listed
in Table 1. The strains were maintained in TYGVS
medium [27] at 37 °C under anaerobic conditions (10 %
CO2, 10 % H2, and 80 % N2) in an anaerobic chamber
(Hirasawa, Tokyo, Japan). For the mutant strain, TYGVS
containing 40 μg/ml erythromycin was used.
Sequence homology-based screening
The whole genome sequence of T. denticola ATCC
35405 in the Los Alamos oral pathogen database
(http://www.oralgen.org) was screened for homologous
sequences with the S. mutans bacteriocin immunity pro-
tein (ImmA/Bip) sequence [28] using the protein blast
program. The obtained homologous sequences were
further compared against the database of National Cen-
ter for Biotechnology Information (NCBI, http://blas-
t.ncbi.nlm.nih.gov/Blast.cgi). The DNA sequences coding
for the homologous proteins in T. denticola were desig-
nated as tepA1, A2, and A3 as described in the Results sec-
tion, and they were characterized with Genetyx-MAC v.
17.0.6 (Genetyx Corporation, Tokyo, Japan).
Southern blotting
The prevalence of DNA sequences homologous to
tepA1, A2, and A3 in T. denticola species was detected
by Southern blotting. T. denticola was grown for 3 days
in TYGVS medium and genomic DNA was isolated with
the Gentra Puregene Cell Kit (Qiagen, Tokyo, Japan).
Southern blot analysis was performed as described previ-
ously [29]. Digoxigenin-labeled primer was synthesized
on a GeneAmp 9700 thermal cycler (Life Technologies,
Carlsbad, CA) with the PCR DIG Probe Synthesis Kit
(Roche Diagnostics, Tokyo, Japan) according to the man-
ufacturer’s instructions using the 3 primer pairs I-1F and
I-1R, I-2F and I-2R, and I-3F and I-3R, for tepA1, tepA2,
and tepA3, respectively (Table 2). Hybridized bands were
detected with the DIG Nucleic Acid Detection Kit
(Roche Diagnostics).
Construction of a tepA2 mutant
As TepA2 showed similarity to ImmA, a tepA2-deficient
mutant of T. denticola ATCC 35405 was constructed by
allelic exchange mutation to investigate the role of
tepA2. Briefly, two fragments flanking the tepA2 gene
were amplified with primer pairs 718D/719U and 719D/
720U (listed in Table 2), respectively. The ermF-ermAM
cassette was amplified with the primers EMD2 and
EMU2 and the fragment was inserted between the up-
stream and downstream fragments using the PCR-based
overlap-extension method [30]. The constructed frag-
ments were introduced by electroporation and transfor-
mants were isolated on TYGVS agar plates containing
40 μg/ml erythromycin as described previously [29].
Inactivation of the gene in mutant KT-3 was confirmed
by Southern blot and PCR analyses.
Antibiotic susceptibility testing
The effect of tepA2 inactivation on the susceptibility of
T. denticola to antibiotics was investigated. Chloram-
phenicol, ofloxacin, and kanamycin, to which T. denti-
cola showed low susceptibility in our preliminary results,
were selected. T. denticola ATCC 35405 and KT-3 were
cultured as described above for 4 days. The cells were
adjusted to an optical density at 660 nm (OD660) of 0.1
with TYGVS medium using a spectrophotometer (UV-
Table 1 List of the strains used in this study
Bacterial strain Relevant characteristics Source or reference
T. denticola ATCC 33520 Ems [41]
T. denticola ATCC 33521 Ems [41]
T. denticola ATCC 35404 Ems [41]
T. denticola ATCC 35405 Ems [41]
T. denticola GM1 Ems [42]
T. denticola KT-3 tepA2:: Emr This study
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2550, Shimadzu, Kyoto, Japan), and 100 μl of the cell
suspension was added to TYGVS containing 0.5–1 μg/
ml of chloramphenicol, 16–64 μg/ml of kanamycin, or
8–32 μg/ml of ofloxacin. After incubation for 7 days
under anaerobic conditions, cell growth was measured
at OD660 with the spectrophotometer.
DNA microarray analysis
T. denticola ATCC 35405 and KT-3 were cultured as
described above for 2 days. To investigate the relation
between inactivation of tepA2 and increase of chloram-
phenicol resistance, exponentially growing cells (OD660
~ 0.2) were incubated with chloramphenicol (1 μg/ml)
for 4 h. The cells were harvested immediately after
chloramphenicol treatment and total RNA was extracted
using Trizol (Life Technologies). DNase treatment was
carried out using a TURBO DNA-free kit Life Technolo-
gies). cDNA was synthesized using a SuperScript
Double-Stranded cDNA Synthesis kit (Invitrogen). DNA
microarray gene expression analysis was carried out
using Roche NimbleGen custom arrays (2006-07-
27_TI243275_60mer; Roche, Indianapolis, IN) according
to the standard NimbleGen procedure (NimbleGen ar-
rays user’s guide: gene expression analysis, v6.0).
Briefly, cDNA (0.5–1 μg) was labeled using a Nimble-
Gen one-color labeling kit, in which Cy3 was ran-
domly incorporated into the newly synthesized DNA
by the Klenow fragment. Labeled cDNA (3 μg) de-
rived from each RNA sample was hybridized with
each array for 16 to 18 h. The slides were washed,
spun dry, and scanned with an Agilent Microarray
Scanner with a resolution of 5 μm. Normalization
was carried out with the NimbleScan 2.6.0.0 built-in
normalization function. Target genes were confirmed
by real-time PCR analysis using primers listed in
Table 2.
Quantitative reverse transcription (qRT) PCR expression
analysis of tepA1-B1, tepA3-B3, and TDE_0820
To investigate the relationships among tepA1, A2 and
A3, expression of tepA1 and A3, tepB1 and B3, and
TDE_0820 in the wild-type strain and KT-3 were evalu-
ated. T. denticola ATCC 35405 and KT-3 were cultured
as described above. Cells at mid-log phase (OD660 of
0.4–0.6) were harvested and total RNA was extracted
using Trizol (Life Technologies). DNase treatment was
carried out using a TURBO DNA-free kit (Life Tech-
nologies) and cDNA was synthesized using ReverTra
Ace (Toyobo, Osaka, Japan). Gene expression was mea-
sured with real-time PCR using primers and the Taqman
probe (Life Technologies) listed in Table 2 on a 7500
Real-Time PCR System (Life Technologies). Expression
of each gene was normalized to the level of 16S rRNA as
an internal control and was expressed as a fold modula-
tion relative to the wild-type strain grown without
chloramphenicol.
Statistical analysis
Comparisons of gene expression and susceptibility to an-
tibiotics were carried out using Student’s t-test. One-way
ANOVA followed by Tukey’s multiple comparison test
was used for comparisons of gene expression among the
two strains grown with or without chloramphenicol. All
tests were carried out using Prism v. 5f (GraphPad soft-
ware, San Diego, CA). The level of significance for all
statistical tests was set at P < 0.05.
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Results
Screening of homologous sequences for bacterial
immunity proteins in T. denticola
A search against the T. denticola ATCC 35405 whole
genome sequence for sequences homologous to S.
mutans ImmA revealed an amino acid sequence that
possesses 26 % identity with ImmA between residues 5
and 70 (Fig. 1). The sequence is coded by a 2154-bp
open reading frame, TDE_0719, and consists of 717
amino acids. The calculated molecular mass of the
deduced amino acid sequence is 80279.25, and the esti-
mated pI is 8.76. The TDE_0719 sequence was com-
pared to the NCBI nucleotide sequence database. The
DNA sequence from bp 1408 to 2059, which codes for
amino acid residues 469 to 686, shows 60–70 % identity
with ABC transporters of T. denticola ATCC 35405,
Clostridium botulinum, and Spirochaeta caldaria. This
region encodes part of a potential ATP-binding site. The
amino acid sequence shows 45 % identity with the bac-
teriocin ABC transporter of Spirochaeta africana DSM
8902 in a 713-amino-acid overlap, 46 % identity with
that of Clostridium lentocellum DSM 5427 in a 713-
amino-acid overlap, and 47 % identity with that of Clos-
tridium clariflavum DSM 19732 in a 710-amino-acid
overlap. In addition to these sequences, amino acid
sequences deduced from TDE_0425 and TDE2431 in T.
denticola ATCC 35405, which were not detected in the
first screening using S. mutans ImmA, also show
homology with that coded by TDE_0719 (43 % in a 715-
amino-acid overlap and 40 % in a 710-amino-acid
overlap, respectively).
A search of the NCBI Conserved Domain Database
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml)
revealed that amino acid residues 1–140 of TDE_0719
display similarity to the peptidase C39B domain, residues
160–420 to the ABC membrane superfamily, and resi-
dues 480–717 to the P-loop NTPase superfamily. Do-
mains of the ABC membrane superfamily and the P-loop
NTPase superfamily are common features of bacterial
transporters [31]. Multiple comparisons with other bac-
teriocin ABC transporters are depicted in Fig. 2. The Q,
C, and H residues form the putative active site of a sub-
family of the peptidase family C39, which mostly consists
of bacteriocin-processing endopeptidases from bacteria
[32], and are conserved in the corresponding regions of
TDE_0425, TDE_0719, and TDE2431. The ABC trans-
porter signature motif LSGGQRQRIA and GS-KTT, Q,
DE, and H, which are observed at ATP-binding sites [33],
were highly conserved in the corresponding regions of the
T. denticola sequences. We designated the three open
reading frames TDE_0425, TDE_0719, and TDE2431 as
Treponema exporter proteins A1, A2, and A3 (tepA1,
tepA2, and tepA3 genes), respectively.
TDE_0720, which is located immediately downstream
of TDE_0719, displayed similarity to the multidrug re-
sistance efflux pump of Spirochaeta africana DSM 8902
(22 % identity in a 369-amino-acid overlap) and the
HlyD family secretion protein of Desulfosporosinus sp.
OT (27 % identity in a 459 amino-acid overlap). The
region of TDE_0720 spanning residues 240 to 350 had
similarity to a domain of a HlyD family secretion protein
(pfam13437) that is reported to be part of an accessory
protein for ABC exporters of gram-negative bacteria for
translocating proteins across the outer membrane [31].
Downstream of tepA1 and tepA3, TDE_0426 and
TDE2430 were detected, and both also showed similarity
to sequences coding HlyD family secretion proteins. The
presence of the C39B peptidase domain, a conserved
ATP-binding motif, a membrane-spanning domain, and
a nearby accessory protein facilitating export is consist-
ent with the properties of a bacterial ABC exporter.
Therefore, we designated TDE_0426, TDE_0720, and
TDE2430 as Treponema exporter proteins B1, B2, and
B3 (tepB1, tepB2, and tepB3), respectively.
Bacteriocin transporters are reported to cleave the
double-glycine leader peptides from the precursors of
bacteriocins for their secretion [31]. A search of the
flanking regions of tepA1, A2, and A3 in the genome
sequence of T. denticola ATCC 35405 revealed that pro-
teins coded by three open reading frames (TDE_0416,
TDE_0422, and TDE_0423) upstream of tepA1 have
double-glycine bacteriocin-type signal domains. How-
ever, no double glycine-containing protein-coding se-
quence exists near tepA2 and A3. Of the three proteins,
those coded by TDE_0422 and TDE_0424 showed high
overall similarity (92 %). The protein coded by
TDE_0416 showed high sequence identity with
TDE_0422 and TDE_0424 (98 % and 84 %, respectively);
Fig. 1 Homology between the S. mutans bacteriocin immunity protein ImmA and the deduced amino acid sequence of TDE_0719 in T.
denticola ATCC35405
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Fig. 2 (See legend on next page.)
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however, the sequence was truncated at residue 167.
TDE_0422 and TDE_0424 showed only weak similarity
to penicillin-binding proteins of Bacillus cereus VD148
(37 % identity in a 89-amino-acid overlap).
Prevalence of tepA1, A2, and A3 in T. denticola strains
We examined the presence of the three tepA1, A2, and A3
sequences in T. denticola strains ATCC 33520, ATCC
33521, ATCC 35404, ATCC 35405, and GM1 by Southern
blotting (Fig. 3). As a single band of approximately 9 kbp
was detected in ATCC33520, ATCC33521, and ATCC
35405 with the tepA1 probe; a band at approximately 2 kb
was detected from ATCC 35405 and GM1 with the tepA2
probe; and all strains exhibited two bands at approxi-
mately 1.5 kb and 0.8 kb with the tepA3 probe.
Antimicrobial sensitivity of the tepA2-deficient mutant
Among the three bacteriocin transporter-like se-
quences, we focused on TepA2 because it showed the
highest similarity to ImmA. Bacteriocin-like sequences
were not detected around tepA2 and B2. Therefore, it is
possible that the protein transports other molecules in
addition to a bacteriocin. To characterize the function
of tepA2 and the functional interaction among the three
exporter genes, a tepA2-deficient mutant of strain
ATCC 35405 was constructed and designated KT-3.
Inactivation of tepA2 did not affect the growth of T.
denticola (data not shown). Various ABC export sys-
tems transport non-protein molecules such as lipophilic
drugs, antibiotics, and polysaccharides [31]. To investi-
gate the possible involvement of tepA2 in antibiotic
export, the susceptibility of strain 35405 against chlor-
amphenicol, kanamycin, and ofloxacin was evaluated.
In the presence of 1 μg/ml chloramphenicol, the growth
of the wild type was completely inhibited while T.
denticola KT-3 showed 40.0 % growth relative to the
control (Fig. 4). In the presence of 16–64 μg/ml of
kanamycin, the growth of T. denticola KT-3 was signifi-
cantly lower than that of the wild-type strain. In the
presence of 16–32 μg/ml of ofloxacin, the growth rate
of T. denticola KT-3 was higher than that of the wild-
type. These results indicated that inactivation of tepA2
might influence the susceptibility of T. denticola to
these antimicrobials.
DNA microarray analysis of the tepA2-deficient mutant
In the tepA2-deficient mutant, susceptibility against
kanamycin decreased while that to chloramphenicol and
ofloxacin increased. To investigate the mechanisms of
the increase in susceptibility against chloramphenicol,
the gene expression profiles of T. denticola ATCC 35405
and KT-3 during exposure to chloramphenicol were
compared using microarrays. Significantly differentially
expressed genes in KT-3 relative to the wild-type strain
are shown in Tables 3 and 4. Expression of the GNAT
family acetyltransferase, glucosamine-6-phosphate de-
aminase, precorrin-4 C11-methyltransferase, several
(See figure on previous page.)
Fig. 2 Multiple sequence alignments of bacteriocin ABC transporters. Cysteine and histidine, which are part of the putative active site of the peptidase
family C39B, as well as glutamine, which contributes to the oxyanion pore in other cysteine protease families, are marked with * and indicated
in yellow. The ATP-binding site and ABC transporter signature motifs are indicated in yellow and marked with † and #, respectively. The alignment was
carried out using the program Genetyx-Mac 16.0.9. C. divergens: ATP-dependent transporter of Carnobacterium divergens, L. lactis: Lactococcin-A
transport/processing ATP-binding protein LcnC of Lactococcus lactis subsp. lactis, L. mesenteroides: Mesentericin-Y105 transport/processing ATP-binding
protein MesD of Leuconostoc mesenteroides, P. acidilactici: Pediocin PA-1 transport/processing ATP-binding protein PedD of Pediococcus acidilactici,
TDE_0425: tepA1, TDE_0719: tepA2, TDE_2431: tepA3
Fig. 3 Southern blot analysis of tepA1 (a), tepA2 (b), and tepA3 (c). Genomic DNA from T. denticola strains was digested with HindIII. 1: genomic DNA
from ATCC 33520, 2: genomic DNA from ATCC 33521, genomic DNA from ATCC 35404, 4: genomic DNA from ATCC 35405, 5: genomic DNA from GM1
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ABC transporters, and potential transcriptional regula-
tors including TDE_0820 (transcriptional regulator,
TetR family) was increased, while that of methyltrans-
ferase domain protein, several ABC transporters, and
GGDEF domain proteins, as well as pyrrolidone-
carboxylate peptides were decreased. Increases in ex-
pression of tepA1 and tepA3 were detected in the
Fig. 4 Effect of inactivation of tepA2 on the growth of T. denticola in
medium containing chloramphenicol (a), kanamycin (b), or ofloxacin
(c) in the wild-type and tepA2-deficient KT-3 strains. T. denticola was
adjusted to OD660 = 0.1 and inoculated into TYGVS medium containing
antibiotics. Growth of T. denticola was evaluated by measuring
the OD660. The experiments were performed twice in quadruplicate.
Data are presented as the mean ± SD (n = 8). *P < 0.05 vs. ATCC 35405
under the same concentration of antibiotics
Table 3 Genes with increased expression in the tepA2-deficient
mutant in the presence of chloramphenicol
Gene Gene expression fold change
(KT-3 versus wild type)
TDE_0499 hypothetical protein 50.5




TDE_2214 hypothetical protein 17.9







TDE_1848 hypothetical protein 15.2
TDE_0307 hypothetical protein 14.3






TDE_1599 ABC transporter, ATP-binding/
permease protein
12.5




TDE_1517 hypothetical protein 11.1
TDE_1692 hypothetical protein 11.1
TDE_0528 hypothetical protein 11.0
TDE_0475 ABC transporter, ATP-binding
protein
11.0
TDE_2519 hypothetical protein 10.5
TDE_0231 DNA polymerase III,
beta subunit
10.3
TDE_0382 hypothetical protein 9.8
TDE_2638 hypothetical protein 9.5
TDE_0375 ABC transporter, ATP-binding
protein
9.4
TDE_1977 hypothetical protein 9.3




TDE_0426 bacteriocin ABC transporter,
ATP-binding/permease protein, putative
6.1
TDE_2431 bacteriocin ABC transporter,
ATP-binding/permease protein, putative
2.8
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mutant; however, they were weak when compared to those
of the listed genes.
Expression of tepA1-B1, tepA3-B3, and TDE_0820 in the
tepA2 mutant
Among the genes that showed increased expression in the
presence of chloramphenicol in KT-3 were TDE_0259
(transcriptional regulator, MarR family) and TDE_0820,
which code for potential repressor proteins. We selected
TDE_0820 for further evaluation by qRT-PCR because the
change of expression between the wild type and the
mutant was somewhat similar to that of TDE_0259 but its
expression level in the wild type and the mutant was
approximately 10 times higher than that of TDE_0259.
Increases in tepA1 and tepA3 expression were detected,
although these were lower than those of the other genes
in Table 3. To investigate the relationship among the bac-
teriocin ABC transporter genes, tepA1-B1, tepA3-B3 were
also selected for further evaluation by qRT-PCR. The
expression of tepA1 and tepB1 was not affected by the
inactivation of tepA2 (Fig. 5a and b). The expression of
tepA3 and tepB3 was significantly increased by inactiva-
tion of tepA2 (Fig. 5c and d), indicating that it is associated
with tepA2-B2 expression. In the presence of chloram-
phenicol, tepA1 expression was decreased in both the
wild-type strain and KT-3 (Fig. 5a). The expression of
tepA3-B3 did not change with chloramphenicol treatment
in the wild-type strain while it decreased in KT-3 (Fig. 5b
and c). The expression of TDE_0820 was increased in
both the wild-type and KT-3 strains upon chlorampheni-
col treatment; however, the change was significant only in
KT-3 (Fig. 5e). These results indicated that the increased
expression of tepA3-B3 was induced by inactivation of
tepA2 and was independent of exposure to chlorampheni-
col. Expression of TDE_0820 in KT-3 suggested an associ-
ation with chloramphenicol sensitivity.
Discussion
TepA2 shows 42–44 % identity with the bacteriocin ex-
porters of S. africana and C. lentocellum as well as with
two orthologs, TepA1 and TepA3, of T. denticola ATCC
35405. The putative active-site residues for bacteriocin pep-
tidases, membrane-spanning domains, and ATP-binding
sites were conserved in all of the orthologs. Downstream of
the orthologs, sequences for accessory proteins (TepBs),
which showed similarity to the functional domain of hlyd-
like domains, were found. Although bacteriocin production
has not been reported in T. denticola, putative proteins
with double-glycine signal peptides, TDE_0416, TDE_0422,
and TDE_0424 were located upstream of tepA1. These
results tentatively suggest that tepA-tepB may code for
exporter proteins for these proteins.
The Southern blot analysis results indicated that the
number of orthologs of tepA differs among T. denticola
strains. Similarly, diversity among T. denticola strains
has been reported for Msp (major sheath protein) [34].
However, diversity in the number of orthologs has not
yet been documented. Msps are 53–63 kDa and the
identity of the amino acid sequences between T. denti-
cola strains ATCC 35405 and OKT is 43 % [34]. The
amino acid identity among tepAs (40 %) was similar to
that observed among Msps. Only tepA3 was detected in
all tested strains of T. denticola. The genes coding pro-
teins with a bacteriocin-like leader peptide were detected
only upstream of tepA. It is possible that tepA and tepB,
but not the bacteriocin-like genes, were duplicated during
the evolution of T. denticola although further analysis is
required to clarify the duplication events.
Table 4 Genes with decreased expression in the tepA2-deficient
mutant in the presence of chloramphenicol
Gene expression fold change
(KT-3 versus wild type)
TDE_0719 bacteriocin ABC transporter,
ATP-binding/permease protein, putative
0.0004




TDE_2761 hypothetical protein 0.05
TDE_0953 branched-chain amino acid
ABC transporter, permease protein
0.05
TDE_1883 hypothetical protein 0.06
TDE_1066 hypothetical protein 0.06
TDE_2582 GGDEF domain protein 0.06
TDE_1058 hypothetical protein 0.06
TDE_0720 bacteriocin ABC transporter,
bacteriocin-binding protein, putative
0.07
TDE_0998 hypothetical protein 0.09
TDE_1930 hypothetical protein 0.1






TDE_1921 hypothetical protein 0.1
TDE_0485 hypothetical protein 0.1
TDE_0849 hypothetical protein 0.1
TDE_1446 hypothetical protein 0.1
TDE_0894 hypothetical protein 0.1
TDE_2497 hypothetical protein 0.1
TDE_0912 hypothetical protein 0.1
TDE_0243 ABC transporter, ATP-binding
protein
0.1
TDE_2785 hypothetical protein 0.1
TDE_1975 hypothetical protein 0.1
TDE_0485 hypothetical protein 0.1
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In the tepA2-deficient mutant, the expression of tepA3-
B3 increased significantly while that of tepA1-B1 increased
only slightly. In T. denticola, regulation of an ABC trans-
porter has been reported only for a thiamine pyrophos-
phate transporter, which is regulated by a TPP-binding
riboswitch [35]. TepA2-B2 and tepA3-B3 have similarity to
the functional motif for bacteriocin ABC transporters but
they are not proximal to bacteriocin-like genes. Only
tepA1-B1 has a bacteriocin-like protein directly upstream.
A recent report indicated that peptides secreted through a
bacteriocin export system could have signaling functions
[36]. It is possible that a reduction in the export of a
Fig. 5 Expression of tep and TDE_0820 in the presence or absence of chloramphenicol. Expression of tepA1 (a), tepB1 (b), tepA3 (c), tepB3 (d),
TDE_0820 (e) in the presence or absence of chloramphenicol in the wild-type and tepA2-deficient mutant KT-3. Expression levels of each gene
were normalized using 16S rRNA levels as internal controls and are expressed as a fold modulation relative to the wild-type strain grown without
chloramphenicol. Experiments were performed three times in triplicate. Data are presented as the mean ± SD (n = 9). *P < 0.05 vs. ATCC 35405
without chloramphenicol, † P < 0.05 vs. ATCC 35405 with chloramphenicol, § P < 0.05 vs. KT-3 without chloramphenicol
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signaling molecule by tepA2 may affect the expression of
tepA3-B3. The expression of tepA3-B3 increased in the
tepA2 mutant, while that of tepA1-B1 did not. These re-
sults suggest an interaction between regulation of expres-
sion of tepA2-B2 and that of tepA3-B3, and that regulation
of tepA1-B1 is independent of tepA2-B2 and tepA3-B3.
Interestingly, resistance to chloramphenicol and oflox-
acin was increased while resistance to kanamycin was
reduced in the tep2-deficient mutant under conditions
that induced increased tepA3 expression. Bacterial efflux
pumps, including ABC transporters, are involved in drug
resistance in several bacteria [37]. In T. denticola, resist-
ance to antimicrobial agents such as human β-defensin
2 and 3, and rifampicin has been reported [38, 39], and
an ABC transporter was suggested to be involved in
resistance to β-defensin 3. In the microarray analysis,
several genes encoding ABC transporters and potential
transcriptional regulators including TDE_0820 showed
increased expression in the tepA2 mutant as compared
to the wild-type strain. In addition, an acetyltransferase
of the GNAT family exhibited significantly increased
expression in the tepA2 mutant. These changes can
potentially affect the susceptibility against chlorampheni-
col. However, the substrate of the enzyme group was
reported to be kanamycin [40]; thus, the involvement of
the enzyme in chloramphenicol resistance seems un-
likely. The expression of tepA3-B3 in the KT-3 mutant
was higher than that in the wild-type strain, although
the level was low when compared to that in the mutant
without chloramphenicol. It is possible that the changes
in the expression of tepA3-B3 are required for sensitivity
to chloramphenicol. Obviously, further analysis is required
to define the role of these proteins with putative ABC
transporter functions in relation to sensitivity to the three
antibiotics tested in this study.
Conclusions
T. denticola ATCC 35405 has three potential bacteriocin
export proteins and the presence of these genes differs
among the Treponema strains. Furthermore, TepA3-B3
of the proteins may be involved in resistance to chlor-
amphenicol. The changes in susceptibility in T. denticola
may contribute to our knowledge of the use of chemo-
therapy for chronic periodontitis.
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